Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Milestone Pharmaceuticals Inc.
13G/A
Amendment 5
MIST · 59935V107
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 10.0% | ||||
| Roderick Wong, M.D. | 10.0% | ||||
|
Neurogene Inc.
13G/A
Amendment 1
NGNE · 64135M105
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 10.0% | ||||
| Roderick Wong, M.D. | 10.0% | ||||
|
Establishment Labs Holdings Inc.
13G/A
Amendment 6
ESTA · G31249108
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 10.0% | ||||
| Roderick Wong, M.D. | 10.0% | ||||
|
PepGen Inc.
13G
PEPG · 713317105
|
9.8% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 9.8% | ||||
| Roderick Wong, M.D. | 9.8% | ||||
|
ESSA Pharma Inc.
13G/A
Amendment 2
EPIX · 29668H708
|
2.5% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 2.5% | ||||
| Roderick Wong, M.D. | 2.5% | ||||
|
SAB Biotherapeutics, Inc.
13G/A
Amendment 1
SABS · 78397T202
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 10.0% | ||||
| Roderick Wong, M.D. | 10.0% | ||||
|
Spyre Therapeutics, Inc.
13G/A
Amendment 1
SYRE · 00773J202
|
6.2% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 6.2% | ||||
| Roderick Wong, M.D. | 6.2% | ||||
|
Apogee Therapeutics, Inc.
13G
APGE · 03770N101
|
6.0% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 6.0% | ||||
| Roderick Wong, M.D. | 6.0% | ||||
|
Geron Corporation
13G/A
Amendment 1
GERN · 374163103
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 0% | ||||
| Roderick Wong, M.D. | 0% | ||||
|
Cutera, Inc.
13G/A
Amendment 1
CUTRQ · 232109108
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 0% | ||||
| Roderick Wong, M.D. | 0% | ||||
|
Immatics N.V.
13G/A
Amendment 1
IMTX · N44445109
|
5.5% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 5.5% | ||||
| Roderick Wong, M.D. | 5.5% | ||||
|
Axsome Therapeutics, Inc.
13G/A
Amendment 2
AXSM · 05464T104
|
8.4% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 8.4% | ||||
| Roderick Wong, M.D. | 8.4% | ||||
|
Sage Therapeutics, Inc.
13G/A
Amendment 1
SAGE · 78667J108
|
4.9% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 4.9% | ||||
| Roderick Wong, M.D. | 4.9% | ||||
|
Dyne Therapeutics, Inc.
13G/A
Amendment 1
DYN · 26818M108
|
5.1% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 5.1% | ||||
| Roderick Wong, M.D. | 5.1% | ||||
|
Taysha Gene Therapies, Inc.
13G/A
Amendment 1
TSHA · 877619106
|
5.9% |
2/14/2025
Event 12/31/2024
|
|||
| RTW Investments, LP | 5.9% | ||||
| Roderick Wong, M.D. | 5.9% | ||||
|
Allurion Technologies, Inc.
13D/A
Amendment 6
ALUR · 02008G201
|
21.9% |
1/29/2025
Event 1/28/2025
|
|||
| RTW Investments, LP | 21.9% | ||||
| RTW Master Fund, Ltd. | 10.5% | ||||
| RTW Innovation Master Fund, Ltd. | 8.3% | ||||
| Roderick Wong, M.D. | 21.9% | ||||
|
Allurion Technologies, Inc.
13D/A
Amendment 5
ALUR · 02008G201
|
29.6% |
1/16/2025
Event 1/14/2025
|
|||
| RTW Investments, LP | 29.6% | ||||
| Roderick Wong, MD | 29.6% | ||||
|
Allurion Technologies, Inc.
13D/A
Amendment 4
ALUR · 02008G201
|
10.0% |
1/10/2025
Event 1/7/2025
|
|||
| RTW Investments, LP | 10.0% | ||||
| Roderick Wong, M.D. | 10.0% | ||||